Sort
11,323 grants matching “glioblastoma”
Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy
$223,194Susan M Chang · University Of California, San Francisco · P01 · FY2009 · CA
Lactate Transport as a Therapeutic Target in Glioma
$223,009Saroj Priyantha Mathupala · Wayne State University · R01 · FY2007 · CA
Microvesicles as potential genetic biomarkers of brain tumors
$222,971Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2012 · CA
TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM
$222,962Henry S. Friedman · Duke University · P50 · FY2007 · CA
Project 4-Monika Rak
$222,838Monika Rak · Lsu Health Sciences Center · P20 · FY2025 · GM
Dysregulation of mTORC2 in gliomas
$222,812Joseph F Gera · Brentwood Biomedical Research Institute · R01 · FY2014 · CA
Using artificial intelligence and MRI to address limitations in glioblastoma
$222,751Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Proteogenomic characterization and biomarker discovery in glioblastoma
$222,751Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Prognostic and predictive clinical and proteomic biomarker discovery in GBM
$222,751Andra Krauze · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Modeling low-grade gliomas using human pluripotent stem cells
$222,750Rui Zhao · University Of Alabama At Birmingham · R21 · FY2019 · NS
Highly multiplexed live-cell GPCR arrays for drug discovery in glioma.
$222,717Jonathan W Jarvik · Spectragenetics · R41 · FY2021 · CA
Targeting the PI3K Pathway in Malignant Glioma
$222,389W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
$222,359John Anthony Muraski · Endurx Pharmaceuticals, Inc. · R44 · FY2014 · CA
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
$222,309Anita Borton Hjelmeland · University Of Alabama At Birmingham · R01 · FY2013 · CA
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment
$222,255Lauren Keith · Imbio, Llc · R44 · FY2016 · CA
EGFR MUTATIONS IN MALIGNANT GLIOMAS
$222,233Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · CA
EGFR MUTATIONS IN MALIGNANT GLIOMAS
$222,233Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2000 · CA
Dual responsive nanoparticle for brain targeted drug delivery
$222,223Peisheng Xu · University Of South Carolina At Columbia · P20 · FY2017 · GM
AI-Based Modeling and Drug Development
$222,049Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
A new kinase inhibitor for glioblastoma
$221,850Raymond Daniel Blind · Vanderbilt University Medical Center · R21 · FY2019 · CA
Role of LAP positive immune cells in glioblastoma pathogenesis
$221,823Howard L Weiner · Brigham And Women'S Hospital · R21 · FY2015 · NS
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2022 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2024 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2021 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2023 · CA